Browse Arkansas Code titles and sections
42 U.S.C. § 283r — National Science Advisory Board for Biosecurity
Federal law — U.S. Code and appendices · legal_authorities
**(a) Establishment** The Secretary, acting through the Director of NIH, shall establish an advisory committee, to be known as the “National Science Advisory Board for Biosecurity” (referred to in this section as the “Board”).
**(b) Duties**
(1) **11 So in original. No par. (2) has been enacted. In general** — The National Science Advisory Board for Biosecurity referred to in section 205 of the Pandemic and All-Hazards Preparedness Act (Public Law 109–417) (referred to in this section as the “Board”) shall provide technical advice, guidance, or recommendations, to relevant Federal departments and agencies related to biosafety and biosecurity oversight of biomedical research, including—
(A) oversight of federally-conducted or federally-supported dual use biomedical research, such as the review of policies or frameworks used to assess and appropriately manage safety and security risks associated with such research, taking into consideration national security concerns, the potential benefits of such research, considerations related to the research community, transparency, and public availability of information, and international research collaboration; and
(B) continuing to carry out the activities required under section 205 of the Pandemic and All-Hazards Preparedness Act (Public Law 109–417).
**(c) Considerations** In carrying out the duties under subsection (b), the Board may consider strategies to improve the safety and security of biomedical research, including through—
(1) leveraging or using new technologies and scientific advancements to reduce safety and security risks associated with such research and improve containment of pathogens; and
(2) outreach to, and education and training of, researchers, laboratory personnel, and other appropriate individual
Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 283r
Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: 2a8a817d74cd6d7f04c82691d7805594050cda2180aabc275067fe78ada74298. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:record_usc_c285ab2768118cc26ea4067f
Source file: Laws/federal/codes/united-states-code/title-42/section-283r-national-science-advisory-board-for-biosecurity--8e7ff8fa2b.md
Pages: Not recorded – Not recorded
Passage SHA-256: 08a11df4a1e6a57ee71516c12c537cb9f8b8f2e6fa6e43cc0ca21a6ea8ac323d
Source location: Title 42, Chapter 6A, § 283r; chapter-6a-public-health-service.md
Stored source content
**(a) Establishment** The Secretary, acting through the Director of NIH, shall establish an advisory committee, to be known as the “National Science Advisory Board for Biosecurity” (referred to in this section as the “Board”).
**(b) Duties**
(1) **11 So in original. No par. (2) has been enacted. In general** — The National Science Advisory Board for Biosecurity referred to in section 205 of the Pandemic and All-Hazards Preparedness Act (Public Law 109–417) (referred to in this section as the “Board”) shall provide technical advice, guidance, or recommendations, to relevant Federal departments and agencies related to biosafety and biosecurity oversight of biomedical research, including—
(A) oversight of federally-conducted or federally-supported dual use biomedical research, such as the review of policies or frameworks used to assess and appropriately manage safety and security risks associated with such research, taking into consideration national security concerns, the potential benefits of such research, considerations related to the research community, transparency, and public availability of information, and international research collaboration; and
(B) continuing to carry out the activities required under section 205 of the Pandemic and All-Hazards Preparedness Act (Public Law 109–417).
**(c) Considerations** In carrying out the duties under subsection (b), the Board may consider strategies to improve the safety and security of biomedical research, including through—
(1) leveraging or using new technologies and scientific advancements to reduce safety and security risks associated with such research and improve containment of pathogens; and
(2) outreach to, and education and training of, researchers, laboratory personnel, and other appropriate individuals with respect to safety and security risks associated with such research and mitigation of such risks.
**(d) Membership** The Board shall be composed of the following:
(1) Non-voting, ex officio members, including the following:
(A) At least one representative of each of the following:
(i) The Department of Health and Human Services.
(ii) The Department of Defense.
(iii) The Department of Agriculture.
(iv) The Department of Homeland Security.
(v) The Department of Energy.
(vi) The Department of State.
(vii) The Office of Science and Technology Policy.
(viii) The Office of the Director of National Intelligence.
(B) Representatives of such other Federal departments or agencies as the Secretary determines appropriate to carry out the requirements of this section.
(2) Individuals, appointed by the Secretary, with expertise in biology, infectious diseases, public health, ethics, national security, and other fields, as the Secretary determines appropriate, who shall serve as voting members.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Regulatory control of certain biological agents and toxins**
(1) **List of biological agents and toxins**
(A) *In general* — The Secretary shall by regulation establish and maintain a list of each biological agent and each toxin that has the potential to pose a severe threat to public health and safety.
(B) *Criteria* — In determining whether to include an agent or toxin on the list under subparagraph (A), the Secretary shall—
(i) consider—
(I) the effect on human health of exposure to the agent or toxin;
(II) the degree of contagiousness of the agent or toxin and the methods by which the agent or toxin is transferred to humans;
(III) the availability and effectiveness of pharmacotherapies and immunizations to treat and prevent any illness resulting from infection by the agent or toxin; and
(IV) any other criteria, including the needs of children and other vulnerable populations, that the Secretary considers appropriate; and
(ii) consult with appropriate Federal departments and agencies and with scientific experts representing appropriate professional groups, including groups with pediatric expertise.
(2) **Biennial review** — The Secretary shall review and republish the list under paragraph (1) biennially, or more often as needed, and shall by regulation revise the list as necessary in accordance with such paragraph.
**(b) Regulation of transfers of listed agents and toxins** The Secretary shall by regulation provide for—
(1) the establishment and enforcement of safety procedures for the transfer of listed agents and toxins, including measures to ensure—
(A) proper training, including with respect to notification requirements under this section, of—
(i) individuals who are involved in the handling and use of
Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 262a
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
Page 670
TITLE 42—THE PUBLIC HEALTH AND WELFARE
§ 283r
1 So in original. No par. (2) has been enacted.
(1) Identifying and funding areas of bio-
medical science that could realize significant
advancements through a prize competition.
(2) Improving health outcomes, particularly
with respect to human diseases and condi-
tions—
(A) for which public and private invest-
ment in research is disproportionately small
relative to Federal Government expendi-
tures on prevention and treatment activities
with respect to such diseases and conditions,
such that Federal expenditures on health
programs would be reduced;
(B) that are serious and represent a signifi-
cant disease burden in the United States; or
(C) for which there is potential for signifi-
cant return on investment to the United
States.
(b) Tracking; reporting
The Director of the National Institutes of
Health shall—
(1) collect information on—
(A)
the
effect
of
innovations
funded
through the prize competitions under this
section in advancing biomedical science or
improving health outcomes pursuant to sub-
section (a); and
(B) the effect of the innovations on Fed-
eral expenditures; and
(2) include the information collected under
paragraph (1) in the triennial report under sec-
tion 283 of this title (as amended by section
2032).
(Pub. L. 114–255, div. A, title II, § 2002, Dec. 13,
2016, 130 Stat. 1047.)
Editorial Notes
REFERENCES IN TEXT
Section 2032, referred to in subsec. (b)(2), means sec-
tion 2032 of Pub. L. 114–255.
CODIFICATION
Section was enacted as part of the 21st Century Cures
Act, and not as part of the Public Health Service Act
which comprises this chapter.
§ 283r. National Science Advisory Board for Bio-
security
(a) Establishment
The Secretary, acting through the Direct
Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 283r
Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.